Succinate Mediates Tumorigenic Effects via Succinate Receptor 1: Potential for New Targeted Treatment Strategies in Succinate Dehydrogenase Deficient Paragangliomas

Dieter M. Matlac, Katerina Hadrava Vanova, Nicole Bechmann, Susan Richter, Julica Folberth, Hans K. Ghayee, Guang Bo Ge, Luma Abunimer, Robert Wesley, Redouane Aherrahrou, Margo Dona, Ángel M. Martínez-Montes, Bruna Calsina, Maria J. Merino, Markus Schwaninger, Peter M.T. Deen, Zhengping Zhuang, Jiri Neuzil, Karel Pacak, Hendrik LehnertStephanie M.J. Fliedner^*

^*Corresponding author for this work

Clinic of Gynecology and Obstetrics
Institute of Experimental and Clinical Pharmacology and Toxicology
Institute of Cardiogenetics
Clinic of Internal Medicine I

Eunice Kennedy Shriver National Institute of Child Health and Human Development
Universitätsklinikum Carl Gustav Carus
University of Florida
Shanghai University of Traditional Chinese Medicine
Radboud University Nijmegen
Spanish National Cancer Research Centre
National Cancer Institute
Karakter Child and Adolescent Psychiatry University Centre
National Institutes of Health
Griffith University

Sort by
Weight
Alphabetically

Succinate Mediates Tumorigenic Effects via Succinate Receptor 1: Potential for New Targeted Treatment Strategies in Succinate Dehydrogenase Deficient Paragangliomas

Fingerprint

Biochemistry, Genetics and Molecular Biology

Neuroscience

Medicine and Dentistry